A novel lipid A from Halomonas magadiensis inhibits enteric LPS‐induced human monocyte activation

Lipopolysaccharide (LPS) endotoxin is the bacterial product responsible for the clinical syndrome of Gram‐negative septicemia and endotoxic shock. During sepsis, microbial antigens, such as LPS, activate monocytes and macrophages to produce several pro‐inflammatory cytokines, among which tumor necro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European Journal of Immunology 2006-02, Vol.36 (2), p.354-360
Hauptverfasser:	Ialenti, Armando, Di Meglio, Paola, Grassia, Gianluca, Maffia, Pasquale, Di Rosa, Massimo, Lanzetta, Rosa, Molinaro, Antonio, Silipo, Alba, Grant, William, Ianaro, Angela
Format:	Artikel
Sprache:	eng
Schlagworte:	Cell Line Drug Antagonism Escherichia coli Escherichia coli - chemistry Halomonas Halomonas - chemistry Halomonas - immunology Halomonas magadiensis Humans Lipid A - immunology Lipid A - pharmacology Lipid A - therapeutic use Lipid A Macrophage Activation - drug effects Macrophage Activation - immunology Monocytes Monocytes - immunology Shock, Septic - drug therapy Shock, Septic - immunology Shock, Septic - pathology Species Specificity TNF‐α Toll-Like Receptor 4 - immunology Toll‐like receptor 4 Tumor Necrosis Factor-alpha - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!